VistaGen Therapeutics (VTGN) Earnings Date & Reports

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

VTGN is expected to report earnings to fall 44.44% to -25 cents per share on August 06

VistaGen Therapeutics VTGN Stock Earnings Reports

Q2'26

Est.

$-0.25

Q4'25

Beat

by $0.28

Q3'25

Missed

by $0.01

Q2'25

Beat

by $0.14

Q1'25

Beat

by $0.41

The last earnings report on February 12 showed earnings per share of -44 cents, beating the estimate of -73 cents. With 847.19K shares outstanding, the current market capitalization sits at 9.29M.

View a ticker or compare two or three

VTGN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days